|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 161.70 EUR | +1.92% |
|
+0.12% | +36.23% |
| 08-04 | Marengo Therapeutics, Inc. and Ipsen S.A. Nominate First Drug Candidate Under Strategic Tristar Collaboration | CI |
| 08-03 | Jefferies Downgrades Ipsen to Underperform, Boosts PT | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 1,285.12 | +9.85% | 26 | ||||||
| 271.73 | +5.49% | 22 | ||||||
| 273.39 | +11.04% | 28 | ||||||
| 363.92 | -0.21% | 18 | ||||||
| 154.05 | -0.07% | 21 | ||||||
| 211.41 | +30.43% | 22 | ||||||
| 371.93 | -8.8% | 29 | ||||||
| 315.7 | +7.27% | 24 | ||||||
| 157.37 | +19.44% | 27 | ||||||
| 28.98 | +12.28% | 26 | ||||||
| 66.21 | +4.05% | 24 | ||||||
| 559.28 | +15.36% | 25 | ||||||
| 21.51 | +12.31% | 20 | ||||||
| 94.45 | +26.78% | 23 | ||||||
| 9,513.33 | +42.24% | 15 | ||||||
| 56.81 | +15.41% | 18 | ||||||
| 6,375.19 | +20.99% | 16 | ||||||
| 80.33 | +50.05% | 15 | ||||||
| Average | 1,122.26 | +15.22% | 22 | ||||||
| Weighted average by Cap. | 708.09 | +10.06% | 24 |
- Stock Market
- Stocks
- IPN Stock
- 0MH6 Stock
- Sector Ipsen
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
